Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2017-05-23 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2016年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2016 Annual General Meeting (AGM) of the company. It discusses the legality and procedures of the AGM, including the convening, attendance, voting procedures, and results of the shareholder meeting. It does not contain the actual annual report or financial statements but rather focuses on the legal compliance and validation of the AGM process and voting outcomes. The document is relatively short (3143 characters) and is clearly a legal opinion related to the AGM, not the AGM materials themselves or the annual report. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports on the official voting results and legality of the AGM proceedings.
2017-05-23 Chinese
2016年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2016 Annual General Meeting Resolution Announcement" and details the resolutions passed at the 2017 AGM for the fiscal year 2016. It includes voting results on various agenda items such as the 2016 annual report, board and supervisory reports, financial statements, profit distribution plan, and appointment of auditors. The document is primarily focused on announcing the voting results and decisions made at the AGM rather than presenting the full annual report or financial statements themselves. The length is under 5,000 characters and it is a formal announcement of the meeting outcomes. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2017-05-23 Chinese
关于召开2016年年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement regarding the convening of the 2016 Annual General Meeting (AGM) of the company, including the date, voting methods, meeting agenda, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather serves as a notice and procedural guide for the AGM. The document length is 3314 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2017-05-17 Chinese
关于对上海证券交易所问询函回复的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from 中源协和细胞基因工程股份有限公司 responding to an inquiry letter from the Shanghai Stock Exchange regarding media reports about the company's acquisition fund issues, guarantees, and financial risks. It includes extensive disclosures about the company's involvement in leveraged acquisitions, guarantees provided, risk assessments, and related shareholder meeting approvals. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report. It is a regulatory disclosure responding to a regulatory inquiry, providing clarifications and risk disclosures. It does not fit categories like earnings release, management report, or capital update. It is a regulatory filing responding to a regulatory body inquiry and clarifying compliance and risk matters. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2017-05-16 Chinese
2016年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2016 Annual General Meeting (AGM) of the company, dated May 23, 2017. It contains detailed agenda items typical for an AGM, including the presentation and review of the 2016 Annual Report, Board of Directors' work report, Supervisory Board report, financial statements, profit distribution plan, and appointment of the audit firm for 2017. The document includes detailed reports and financial data, not just announcements or summaries. The content is consistent with materials shared during an AGM to inform shareholders and facilitate voting on key company matters. Therefore, this document fits the category of AGM Information (AGM-R).
2017-05-12 Chinese
关于收到上海证券交易所问询函的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company responding to an inquiry letter from the Shanghai Stock Exchange regarding media reports about the company's acquisition activities and related financial guarantees. It includes detailed questions from the exchange and the company's commitment to investigate and respond. The document is a regulatory announcement addressing compliance and disclosure issues, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data but is a formal regulatory communication. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1377 characters), and it is not a report publication announcement or certification letter but a regulatory response.
2017-05-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.